Topic

Zanzalintinib (XL092) [investigational]

A collection of 36 issues

Getting Zanzalintinib (XL092) Covered by UnitedHealthcare in Pennsylvania: Clinical Trial Access and Compassionate Use Appeals Guide

Answer Box: Your Fastest Path to Zanzalintinib Coverage Getting Zanzalintinib (XL092) covered by UnitedHealthcare in Pennsylvania requires clinical trial enrollment or compassionate use approval, since this investigational TKI has no FDA approval. Your three options: (1) Enroll in an active STELLAR program trial where UnitedHealthcare covers routine monitoring costs, (2)

Getting Zanzalintinib (XL092) Covered by Cigna in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Zanzalintinib (XL092) Covered by Cigna in Michigan Zanzalintinib (XL092) is investigational and typically not covered by Cigna outside clinical trials or compassionate use programs. Your fastest path: 1) Check if you qualify for an Exelixis expanded access program, 2) Have your oncologist submit a detailed prior authorization

Getting Zanzalintinib (XL092) [investigational] Covered by Humana in New York: Clinical Trial Access and Compassionate Use Pathways

Answer Box: Your Fastest Path to Zanzalintinib (XL092) Access Zanzalintinib is investigational—Humana won't cover it as a standard drug. Your three pathways: 1) Clinical trials (search ClinicalTrials.gov for "XL092" or "zanzalintinib"), 2) Exelixis Expanded Access Program (free drug, insurance covers routine care)

Getting Zanzalintinib (XL092) Covered by Humana in Illinois: Clinical Trial Access and Compassionate Use Appeals

Quick Answer: Zanzalintinib (XL092) is an investigational cancer drug not yet FDA-approved, so Humana typically won't cover it outside clinical trials. Your fastest path: 1) Ask your oncologist to check active trials at ClinicalTrials.gov, 2) If trial-ineligible, request compassionate use through Exelixis, 3) Submit Humana formulary exception

The Requirements Checklist to Get Zanzalintinib (XL092) Covered by Humana in Georgia: Clinical Trials, Appeals, and Compassionate Use Pathways

Answer Box: Getting Zanzalintinib (XL092) Coverage in Georgia Zanzalintinib (XL092) is investigational with no FDA approval, making standard Humana coverage unlikely. Your fastest path: 1) Check eligibility for active clinical trials (drug provided free), 2) Contact Exelixis Medical Affairs for compassionate use if trial-ineligible, or 3) Submit prior authorization with

The Requirements Checklist to Get Zanzalintinib (XL092) Covered by UnitedHealthcare in Georgia: Appeals, Compassionate Use, and Clinical Trial Access

Answer Box: Getting Zanzalintinib (XL092) Covered by UnitedHealthcare in Georgia Zanzalintinib (XL092) is an investigational cancer drug not FDA-approved, making UnitedHealthcare coverage unlikely outside clinical trials. Your fastest path: 1) Apply for Exelixis's Expanded Access Program (drug provided free), 2) Submit UnitedHealthcare prior authorization for routine care costs

How to Get Zanzalintinib (XL092) Covered by Humana in Virginia: Appeals Guide for Investigational Cancer Treatment

Answer Box: Getting Zanzalintinib (XL092) Coverage from Humana in Virginia Zanzalintinib (XL092) is investigational and typically denied by Humana as "not covered outside clinical trials." However, you have three main pathways: 1) Request a formulary exception with strong medical necessity documentation, 2) Apply for Exelixis' compassionate use

Getting Zanzalintinib (XL092) Covered by UnitedHealthcare in Michigan: Clinical Trials, Compassionate Use, and Appeals Guide 2025

Answer Box: Your Path to Zanzalintinib Access Zanzalintinib (XL092) is an investigational drug not yet FDA-approved. UnitedHealthcare typically denies coverage outside clinical trials. Your fastest path: 1) Search active trials at ClinicalTrials.gov for "XL092" or contact your oncologist about STELLAR program studies, 2) If trial-ineligible, pursue Exelixis

How to Get Zanzalintinib (XL092) Covered by Aetna CVS Health in Washington: Clinical Trial Access, Appeals & Timelines

Answer Box: Getting Zanzalintinib (XL092) Covered by Aetna CVS Health in Washington Zanzalintinib (XL092) is an investigational drug not FDA-approved, so standard Aetna CVS Health coverage is typically denied. The fastest path is through clinical trials (drug provided free by Exelixis) or compassionate use programs where Aetna may cover routine

How to Get Zanzalintinib (XL092) Covered by Cigna in Georgia: Clinical Trial Access, Compassionate Use, and Appeals Guide

Answer Box: Getting Zanzalintinib (XL092) Approved by Cigna in Georgia Zanzalintinib (XL092) is investigational and not on Cigna formularies, but you have three paths: (1) Clinical trial enrollment where Cigna covers routine care costs while Exelixis provides the drug, (2) Compassionate use through Exelixis Medical Affairs with prior authorization for